Senior Director Research Articles

Implementing Change Using Best Practice Program Design Principles

Nico P. Pronk, Ph.D., FACSM, FAWHP,is president of the HealthPartners Institute and chief science officer at HealthPartners in Minneapolis, MN. Dr. Pronk is an affiliate full professor of Health Policy and Management at the University of Minnesota School of Public Health and a visiting scientist at the Harvard University T.H. Chan School of Public Health. He is a past president of the International Association for Worksite Health Promotion (IAWHP), coauthor of the IAWHP Online Certificate Course, editor of ACSM's Worksite Health Handbook, 2nd edition, and associate editor for ACSM's Health & Fitness Journal®. Joel B. Spoonheim, MUP,is the senior director of Worksite Health & Population Well-Being for HealthPartners. As part of an integrated health plan and care delivery system, the department delivers in-person care, virtual care, and well-being improvement solutions in new ways to make health care simpler and more affordable. Joel's teams serve customers ranging from small to Fortune 500 employers, individual consumers, Medicare and Medicaid populations, and individual patients. DisclosureThe authors declare no conflict of interest and do not have any financial disclosures.

A Conversation About Supporting Chinatowns and Cultural Preservation

Award-winning cookbook author, culinary historian, and Chinatown activist Grace Young and Di Gao, senior director of research and development at the National Trust for Historic Preservation, discuss taking action to support historic Chinatowns. American Chinatowns have served as bastions of community resilience and culture for nearly two centuries and continue to serve vital functions for older generations and new immigrants alike. Today, as the world returns to a post-pandemic reality, historic Chinatowns are still fighting for survival. By revealing the everyday stories and testimonies of legacy businesses, mom & pop shops, and residents of Chinatowns through the lens of preserving their ties to place and community, this work contributes vitally to empower and humanize all Americans and reaffirm that their history, identity, and places matter Protecting historic Chinatowns for future generations is vital to fostering understanding of America's complex past and building a more inclusive future.

The Evolution of Medical Communication

Key thought leaders discuss their views of the evolution of medical communication focusing on their grand visions for medical communicators, what we learned from the pandemic, and what will be required in the future. Topics touch on the impact of developing technology, communicating with the public, managing social media, standardizing education requirements, and preparing the next generation of medical communicators. Contributors include: Joan Affleck, MBA, Associate Vice President-Medical Writing, Merck & Co., Inc, Rahway, NJ Dikran Toroser, PhD, CMPP, Senior Director, Publications, Merck & Co., Inc, Rahway, NJ Genevieve Walker, PhD, Freelance Medical Writer, Bridge Health Communications, Portland, OR

Senior Director Q and A: Transition to Practice for Nurse Managers

Senior Director Q and A: Transition to Practice for Nurse Managers

Acknowledging suicidal ideation, depression, and anxiety in PAs

Noël E. Smith is senior director of PA and industry research and analysis for the American Academy of Physician Associates, based in Alexandria, Va. Talia Sierra is an associate professor at Idaho State University in Pocatello, Idaho. Heidi Brown practices in psychiatry in Oregon, Idaho, and Utah, and is an affiliate faculty member in the PA program at Idaho State University in Pocatello, Idaho. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Ask me anything: Jenni Strabley

Jenni Strabley is the senior director of offering management at global quantum-tech company Quantinuum, which offers quantum computing hardware and software solutions.

Providing Access to Genetic Testing Alongside Unparalleled Service and Support

Inside Precision MedicineVol. 9, No. 6 Sponsored ContentProviding Access to Genetic Testing Alongside Unparalleled Service and SupportA Q&A with Megan Martin, MS, CGC, Senior Director Clinical Services, Bionano LaboratoriesPublished Online:9 Jan 2023https://doi.org/10.1089/ipm.09.06.14AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Providing Access to Genetic Testing Alongside Unparalleled Service and Support." Inside Precision Medicine, 9(6), p. 63FiguresReferencesRelatedDetails Volume 9Issue 6Dec 2022 InformationCopyright © GEN PublishingTo cite this article:Providing Access to Genetic Testing Alongside Unparalleled Service and Support.Inside Precision Medicine.Dec 2022.63-63.http://doi.org/10.1089/ipm.09.06.14Published in Volume: 9 Issue 6: January 9, 2023PDF download

The drive for standardization in cellular starting material collection for cell therapy

David McCall, Commissioning Editor, BioInsights, speaks to Anh Nguyen Jones, Senior Director, Cell Therapy Patient Operations, GentiBioAnh Nguyen Jones has over 13 years of Cell and Gene Therapy experience advancing multiple cell therapy programs through clinical and commercial development working closely with Clinical, Commercial, Quality and Technical Operations. Anh joined GentiBio in 2022 as the Senior Director of Patient Operations, leading the teams responsible for the management of cell collection centers, patient scheduling, cell logistics and chain of identity. Prior to joining GentiBio, Anh was Director of Global Apheresis Operations at Bristol Myers Squibb (previously Celgene, Juno Therapeutics) where she led a global team that built and maintained the global network for cell collection centers in support of all cell therapy clinical trials and the commercialization of Breyanzi and Abecma across the globe. Prior to BMS, Anh was in varying roles within Quality Assurance and Apheresis Operations at Dendreon, commercializing the first FDA approved cancer vaccine, Provenge. She holds a BSc in Biochemistry at the University of Washington.

Enabling scalable manufacture of exosomes for future clinical & commercial requirements

David McCall, Commissioning Editor, Cell & Gene Therapy Insights, spoke to Peter Jones, Vice President of CMC, Evox TherapeuticsPeter Jones has over 30 years of experience in the biopharmaceutical industry and is currently Vice President of CMC at Evox Therapeutics. Prior to this, he was Executive Director, Process Development at Autolus Therapeutics, and held several positions of responsibility at Oxford Biomedica, including Senior Director, Head of Operational Strategy, Head of Technical Operations, and Head of Manufacturing Development. Peter also served in multiple senior roles at GlaxoSmithkline and Genzyme in bioprocess development and manufacturing. Peter has a BSc (Hons) in Applied Biology from the University of Hertfordshire and a MSc (Eng) in Biochemical Engineering from University College, London. He is a Chartered Chemical Engineer, Fellow of the Institution of Chemical Engineers and Royal Academy of Engineering. Visiting Professor in Manufacturing of Advanced Therapies at Aston University.

The Myth of The Pipeline Problem: Creating a Diverse and Thriving Team

Corporate leaders issued countless statements decrying racism and investing in diversity, equity, and inclusion (DEI) efforts in 2020. As a result of the pandemic and the ongoing racial reckoning that year, the overlap between societal events and corporate commitments became sharply visible. But the actions on those commitments, less so.Focusing on DEI sparks all sorts of biased statements from colleagues like, “There are no Black/Trans/Women researchers,” “We don't want quality to suffer,” and “There's no pipeline, these folks just aren't out there.”In the face of these false and racist sentiments, researchers, leaders, and managers can create diverse and thriving teams.At the end of this PechaKucha, the audience will have instructions and examples so they can create a diverse and thriving team and support a resilient culture.Shakima Jackson‐Martiniz, Senior Director of DEI at AnswerLab, a research and insights firm, has done just that. In this PechaKucha, she will tell the story of how she increased employee diversity by 29% and is moving forward towards a 50% diversity goal. She'll share the three pillars necessary to create a representative and resilient researcher workforce. She'll describe the challenges she faced along the way and how she addressed them. Ms. Jackson‐Martinez will walk through next steps to foster further inclusivity and belonging at any organization.

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Rupa Pike, PhD is the Senior Director of Technical Affairs for Advanced Therapies, Pharma Services Group at Thermo Fisher Scientific. The Office of Technical Affairs comprises scientific experts that serve as a strategic, innovational and educational leaders in the area of cell-based therapies, plasmids and mRNA therapeutics. In her prior role as the Director of Enterprise Science and Innovation Partnerships, she developed and managed strategic partnerships with global BioPharma, Biotech and Healthcare customers in the area of Cell and Gene Therapy. Prior to this, she was the Head of Technical Operations (Patheon/Thermo Fisher Scientific) where she worked closely with customers to conduct technology transfer and process optimization activities related to GMP manufacturing of cell-based therapies. She has over 15 years of expertise in GMP manufacturing and has successfully led GMP operations, Process Development and MSAT activities, infrastructure buildout, customer relations and business development.Delara Motlagh, PhD the General Manager of Cell Therapy Technologies at Terumo Blood and Cell Technologies, headquartered in Lakewood, Colorado. She is passionate about the cell & gene therapy market and the potential these innovative therapies hold to improve the lives of patients.She brings more than 18 years of experience in biotechnology and healthcare in various therapeutic areas including oncology, cardiology, orthopedics, hematology, and nephrology. Prior to joining Terumo Blood and Cell Therapies in 2017, Delara served in diverse leadership roles at Baxter Healthcare in marketing, research & development, and operations. Her cross-functional background provides a unique perspective and deep understanding of development, cell manufacturing, and commercialization elements in the industry. Delara received a PhD in Physiology and Biophysics from the University of Illinois, fellowship in Vascular Tissue Engineering at Northwestern University, and Executive MBA from Kellogg School of Management.Patrick Hanley, PhD is the Chief and Director of the Cellular Therapy Program and an associate professor of pediatrics at Children’s National Hospital and the George Washington University, respectively. He oversees processing for standard of care stem cell transplantation as well as the development, manufacture, quality, and testing of novel cellular therapies and is responsible for seeking partnerships and commercialization of promising cell and gene therapies. Trained as an Immunologist, Dr Hanley has an extensive background and interest in cellular therapy and is passionate about improving regulations for cellular therapy, training the next generation of cell therapists, and facilitating the translation of new therapeutics. Over the past 15 years he has helped to translate more than 300 products on over 25 cell therapy protocols – ranging from mesenchymal stromal cells to cord blood virus-specific T cells and tumor-associated antigen specific T cells – into the clinic.

Hacking Health Care—Damian Doherty Talks to Tom Lawry About his New Amazon Bestseller

Inside Precision MedicineVol. 9, No. 5 Book ReviewHacking Health Care—Damian Doherty Talks to Tom Lawry About his New Amazon BestsellerTom LawryTom LawryTom Lawry is national director for AI, health and life sciences at Microsoft. In this role he works with health providers, payors, and governments in planning and implementing innovative technology solutions that improve the quality and efficiency of health services delivered around the globe. He focuses on strategies for health information modernization, business intelligence, and performance optimization. He previously served as director of organizational performance for the Microsoft Health Solutions Group. Prior to Microsoft, Tom served as a senior director at GE Healthcare, with global responsibilities for the development of enterprise-wide revenue cycle management and operational performance solutions. Lawry was founder and CEO of a U.S.-based healthcare software company named as one of the top 100 fastest-growing Washington companies for three consecutive years and to the Deloitte Fast 500 Technologies list. He has served in various executive management roles in hospitals and integrated delivery networks in the United States and has published more than 30 articles on topics relating to the use technology and software to innovate healthcare.Search for more papers by this authorPublished Online:22 Oct 2022https://doi.org/10.1089/ipm.09.05.24AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 9Issue 5Oct 2022 InformationCopyright © GEN PublishingTo cite this article:Tom Lawry.Hacking Health Care—Damian Doherty Talks to Tom Lawry About his New Amazon Bestseller.Inside Precision Medicine.Oct 2022.82-87.http://doi.org/10.1089/ipm.09.05.24Published in Volume: 9 Issue 5: October 22, 2022PDF download

AONL Nurse Leader Competencies: Core Competencies for Nurse Leadership

AONL Nurse Leader Competencies: Core Competencies for Nurse Leadership

Know which campus alerts and notifications to deploy to ensure compliance with Clery Act requirements

Institutions of higher education often set their focus on Clery Act crime reporting and classification but fail to account for the equally important Clery Act requirements that guide policy response and action, according to Sarah Barrett, Ph.D., Director of Training and Education at the Clery Center. Barrett, along with Laura Egan, Senior Director of Programs at the Clery Center, shared best practices for Clery Act compliance during a webinar series with Rave Mobile Safety. They offered guidance for determining which type of campus alert or notification to deploy, as required by the Clery Act, along with how to determine communication action plans ahead of time to ensure compliance, and finally, how to use your Clery compliance documents and notifications to raise awareness on your campus of the important work being done to keep your campus safe.

Walmart hikes technician wages in a bid to hire 5,000 this year

Walmart hikes technician wages in a bid to hire 5,000 this year

Social Media 101 for Journals: How to Create and Sustain an Effective Campaign

MODERATOR: Kelly Hadsell Federation of State Medical Boards SPEAKERS: Alexandra Kahler KnowledgeWorks Global @KWF_Info_Mgmt Betsy Donahue Digital Science Philadelphia, Pennsylvania @BetsyDonohue Glenn Landis American Society of Hematology Washington, DC REPORTER: Emilie Gunn American Society of Clinical Oncology Alexandria, Virginia @emiliemgunn More and more journals are using social media these days for many different purposes. Regardless of your organization’s goals in social media, it is important to be strategic about it, and a session at CSE’s 2022 Annual Meeting highlighted some ways that journal editors can launch and sustain a successful social media campaign. Being active on social media is not a “plug and play” type of project. It requires planning before you get started, care and feeding during a campaign, and reflection and analysis once a campaign is complete. All three speaker sessions addressed the various considerations of setting up social media and successfully using it to promote a journal. Getting Started on Social Media Before you get started with a social media channel, make sure you have specific goals for the use of social media. In his presentation, Glenn Landis, Senior Director of Publications at the American Society of Hematology, advised attendees to determine what purpose they want social media to serve for their journals. Some journals use social media to increase engagement between authors and the journal, some want to improve discoverability of their journal content and in turn increase citations, and others use social media to strengthen their brand. Each journal, even if it comes from […]

E. Adam Kallel

E. Adam Kallel, 57, died April 1 in San Diego. “Adam was a kind and thoughtful colleague and a key member of the San Diego scientific community. Adam had a powerful intellect with diverse interests especially in molecular modeling and structure-based drug design (SBDD). In graduate studies with Professor Houk, he made key contributions to the field of torquoselectivity. At Ligand, Adam used SBDD in the identification of the clinical candidate LGD-4665, a thrombopoietin mimetic. He helped build and lead the cheminformatics and modeling departments at several local companies. We will always remember Adam for his generosity of spirit, passion for science, deep knowledge of history, and love for classical music.”—Brad Savall, friend Most recent title: Senior director of computational chemistry, 1859, Inc. Education: BS, chemistry and history, Cal Poly Pomona, 1986; PhD, computational chemistry, University of California, Los Angeles, 1991 Survivors: Mother, Barbara; two adult children To recognize your

Drilling Data Raise Questions About Time of Events and Calculations

Two seemingly simple questions were raised by technical papers about drilling data: What formula did you use? What time did the event occur? For anyone using data to analyze drilling performance or automate the process, getting both those things right is becoming increasingly important. And as drilling relies more on digital controls and sophisticated analysis, getting those data wrong has become a serious problem. One example is the standard measure used for the energy exerted to drill ahead—mechanical specific energy (MSE), for which there are multiple formulas to choose from. And even if the right one is used, its accuracy hangs on whether the needed steps were taken to properly gather the inputs to the formula. Time sounds like a straightforward problem—just ensure all the clocks are in sync. The reality is that there are corporate firewalls blocking access to the reference clocks, a wide range of time-stamping practices, and an increasing amount of calculated data in the information stream based on inputs that are lost in calculation. The MSE problem is simpler to solve but a lot of effort will be required to change the habits, and computer systems, supporting multiple formulas that can deliver significantly different results. Different formulas for MSE and other drilling measures were created over the years for various reasons ranging from the creator’s research interests or a desire to limit the inputs needed for calculating MSE. Pulldown menus on drilling data records have typically offered a menu of MSE options with names for formulas that vary; so, a user would need to know the formula to ensure the correct one was selected. “When the pulldown menu offers a pick list with four types of MSE provided by the vendors, you do not know if you are using the right one now,” said Fred Dupriest, a Texas A&M professor who presented a paper on the issue at the IADC/SPE Drilling Conference and Exhibition in March (SPE 208777). The paper reported on the work of a committee of 15 industry experts who chose a standard MSE formula which was laid out in the paper. It described how to gather the inputs and assigned names for the two approved versions—one for computing energy at the drill bit, and the other that included the drillstring. A second paper presented at the conference described the need to begin a long-term effort to define how to accurately measure, gather, and record time data (IADC/SPE 208732). “If data is not aligned correctly, you are not going to get the right result,” said Pradeep Annaiyappa, a senior director at Nabors for digital data initiatives at the drilling company, when presenting the time-measurement and recordkeeping paper.

Natural Gas—Demand for Security, Energy Transition, and Reliability

1. Robert K. Simmons 1. is a Senior Managing Director at Marathon Capital in New York, NY. (rsimmons{at}marathoncapital.com) The world is currently facing an unprecedented energy crisis that is contributing to an increase in coal use in power production. The geopolitical crisis in Ukraine and the reliance of Europe on Russian gas has motivated the leaders of the Group of Seven to support public investment in gas projects. Energy security has motivated this position, but it is not the only reason. Energy reliability going forward will require that the push to a global reduction of the carbon footprint include natural gas as the long-term fuel necessary toward this goal. Renewables and natural gas energy production working together are not without challenges. However, together they can answer the questions of energy security and reliability, while significantly reducing the global carbon footprint.

Diversity and inclusion in the bioanalytical industry: an interview with Anahita Keyhani.

Anahita Keyhani speaks to Sankeetha Nadarajah, Commissioning Editor.